XLV logo

Health Care Select Sector SPDR Fund (XLV)

$158.54

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on XLV

AUM

$41.90B

P/E ratio

23.9

Dividend yield

1.6004%

Expense ratio

0.08%

Beta

0.613755

Price on XLV

Previous close

$156.82

Today's open

$157.13

Day's range

$157.13 - $158.68

52 week range

$127.35 - $160.59

Profile about XLV

show more

Headquarters

US

Exchange

NYSE Arca

Issue type

Exchange-Traded Fund

XLV industries and sectors

Industries

Health

Top holdings in XLV
News on XLV

XLV is A $41 Billion Defensive Healthcare Play That Looks Good Until You Compare To The S&P 500

Healthcare isn't going anywhere. An aging population, chronic disease management, and breakthrough treatments ensure this sector remains essential regardless of market conditions.

news source

24/7 Wall Street • Feb 18, 2026

news preview

Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?

The State Street Health Care Select Sector SPDR ETF ETF (XLV) was launched on December 16, 1998, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equity market.

news source

Zacks Investment Research • Feb 17, 2026

news preview

Sector Alert: 4 Healthcare ETFs Poised for Explosive Growth Now

Over the past three years, healthcare has been among the worst-performing sectors. 2026's market rotation away from tech is bringing new life to more defensive areas of the market.

news source

The Motley Fool • Feb 11, 2026

news preview

Energy Leads This Year As Tech And Financials Fall Behind

Energy, basic materials, and defensive consumer stocks are in. Tech and financials are out.

news source

Seeking Alpha • Feb 11, 2026

news preview

Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More

Big Pharma delivered strong Q4 2025 results, with most companies beating revenue and EPS expectations and providing generally solid 2026 guidance. Eli Lilly solidified its leadership in obesity and diabetes, outpacing Novo Nordisk, which faces a sharp 2026 revenue decline amid fierce competition, pricing pressure, and other factors.

news source

Seeking Alpha • Feb 7, 2026

news preview

ETFs to Play as Investors Chase Diversification Amid Tech Rout

From "software-mageddon" to rising AI capex pressuring Big Tech, diversification via defensive and global ETFs gains focus.

news source

Zacks Investment Research • Feb 6, 2026

news preview

Energy Leads S&P Sectors in January

Three of the smallest sectors in the S&P 500 delivered the index's strongest performance in January, while the two largest sectors weighed on returns. The broad market index gained modest ground last month, with the State Street SPDR S&P 500 ETF Trust (SPY) up 0.6%, according to ETF Database.

news source

ETF Trends • Feb 3, 2026

news preview

U.S. Consumer Confidence Slumps to Decade Low: ETF Areas to Play

U.S. consumer confidence hits a decade low. Defensive, quality & dividend ETFs like XLP, XLV, XLU, SPHQ & VYM may offer shelter.

news source

Zacks Investment Research • Feb 2, 2026

news preview

2 Hot Sector ETFs Worth Buying in 2026

Index investors and so-called Bogleheads (those who love the Vanguard ETFs) may not be all too fond of the sector ETFs, especially when you consider that simply buying the S&P 500 covers most of one's bases when it comes to diversification.

news source

24/7 Wall Street • Jan 29, 2026

news preview

3 Healthcare ETFs to Buy as Flat Medicare Rate Proposal Hits Insurers

Flat Medicare Advantage rate hikes hit insurers hard, but diversified healthcare ETFs may help investors weather the policy shock.

news source

Zacks Investment Research • Jan 27, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Health Care Select Sector SPDR Fund

Open an M1 investment account to buy and sell Health Care Select Sector SPDR Fund commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in XLV on M1